NLS Pharmaceutics Ltd.

General Information


We are an innovative biopharmaceutical company engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. CNS disorders are a diverse group of conditions that include neurological, psychiatric, and substance use disorders.

Employees: 4
Founded: 2015
Contact Information
Address Alter Postplatz 2, CH-6370 Stans, Switzerland
Phone Number +41.79.779.60.00
Web Address
View Prospectus: NLS Pharmaceutics Ltd.
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $-6.5 mil (last 12 months)
IPO Profile
Symbol NLSP
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $40.3 mil
Manager / Joint Managers Maxim Group LLC
CO-Managers Brookline Capital (A division of Arcadia Securities)
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change